Itamar Medical Ltd

(NASDAQ:ITMR)

Latest On Itamar Medical Ltd (ITMR):

Date/Time Type Description Signal Details
2021-11-18 08:23 ESTNewsItamar Medical EPS beats by $0.23, beats on revenueN/A
2021-09-22 18:32 ESTNewsItamar Medical stock surge on being taken over by Zoll Medical for ~$538MN/A
2021-08-10 18:41 ESTNewsItamar Medical EPS misses by $0.02, beats on revenueN/A
2021-08-10 18:41 ESTNewsItamar Medical Ltd.'s (ITMR) CEO Gilad Glick on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 16:48 ESTNewsTeleflex and Itamar sell off “too draconian”: Piper SandlerN/A
2021-03-09 10:11 ESTAnalyst RatingThe Analyst Target Price has increased from $29.66 to $30.51.Buy
2021-03-03 22:38 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 10:19 ESTAnalyst RatingThe Analyst Target Price has increased from $28.66 to $29.66.Buy
2021-03-03 01:19 ESTNewsItamar Medical Ltd. (ITMR) CEO Gilad Glick on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-02 06:41 ESTNewsItamar Medical EPS beats by $0.12, beats on revenueN/A
2021-02-05 20:56 ESTNewsItamar Medical prices ADSs offeringN/A
2021-02-05 02:59 ESTNewsItamar Medical launches ADS offeringN/A
2021-01-20 10:12 ESTAnalyst RatingThe Analyst Target Price has increased from $28.34 to $28.66.Buy
2021-01-12 18:41 ESTNewsItamar Medical acquires Spry HealthN/A
2021-01-08 12:48 ESTNewsItamar Medical sees Q4 revenue above consensusN/A
2020-12-04 06:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 23:28 ESTEarnings EstimateAn EPS average of -$0.17 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-19 23:28 ESTAnalyst RatingThe Analyst Target Price has increased from $28.06 to $28.34.Buy
2020-11-19 15:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 08:20 ESTNewsItamar Medical Ltd. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-18 15:33 ESTAnalyst RatingThe Analyst Target Price has increased from $27.84 to $28.06.Buy
2020-11-18 04:55 ESTNewsItamar Medical EPS beats by $0.14, beats on revenueN/A
2020-11-18 04:54 ESTNewsItamar Medical Ltd. (ITMR) CEO Gilad Glick on Q3 2020 Results - Earnings Call TranscriptN/A
2020-10-15 07:48 ESTNewsItamar Medical sees Q3 as high as $11M, above consensusN/A
2020-10-15 07:09 ESTAnalyst RatingThe Analyst Target Price has increased from $26.94 to $27.84.Buy
2020-10-14 07:37 ESTAnalyst RatingThe Analyst Target Price has increased from $26.76 to $26.94.Buy
2020-10-08 20:59 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:20 ESTFinancialsCompany financials have been released.Neutral
2020-10-02 10:24 ESTNewsItamar Medical’s WatchPAT300 OK'd in JapanN/A
2020-09-26 16:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-26 08:16 ESTAnalyst RatingThe Analyst Target Price has increased from $25.99 to $26.76.Buy
2020-08-18 03:30 ESTAnalyst RatingThe Analyst Target Price has increased from $24.99 to $25.99.Buy
2020-08-14 12:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 15:33 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 07:50 ESTAnalyst RatingThe Analyst Target Price has increased from $23.74 to $24.99.Neutral
2020-08-12 07:18 ESTNewsItamar Medical EPS beats by $0.16, beats on revenueN/A
2020-08-12 07:18 ESTNewsItamar Medical Ltd. (ITMR) CEO Gilad Glick on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-06 16:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 15:25 ESTAnalyst RatingThe Analyst Target Price has increased from $23.31 to $23.74.Neutral
2020-07-28 16:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:08 ESTFinancialsCompany financials have been released.Neutral

About Itamar Medical Ltd (ITMR):

Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.

ITMR Quotes by TradingView

See Advanced Chart

General

  • Name Itamar Medical Ltd
  • Symbol ITMR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Fiscal Year EndDecember
  • IPO Date2019-03-07
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Web URLhttp://www.itamar-medical.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 8.01
  • Price/Book (Most Recent Quarter) 9.03
  • Enterprise Value Revenue 8.5
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.22
  • Profit Margin -27%
  • Operating Margin -25%
  • Return on Assets -13%
  • Return on Equity -37%
  • Revenue 41.03 million
  • Earnings Per Share -$0.69
  • Revenue Per Share $2.97
  • Gross Profit 28.71 million
  • Quarterly Earnings Growth 30.8%
View More

Highlights

  • Market Capitalization 364.49 million
  • EBITDA -3547000
  • Analyst Target Price $30.51
  • Book Value Per Share $3.06
View More

Share Statistics

  • Shares Outstanding 16.38 million
  • Shares Float 10.04 million
  • % Held by Insiders 441%
  • % Held by Institutions 41.47%
  • Shares Short 283674
  • Shares Short Prior Month 303256
  • Short Ratio 5.63
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.63
  • 52 Week High $26.83
  • 52 Week Low $8.19
  • 50 Day Moving Average 24.39
  • 200 Day Moving Average 21.79
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Itamar Medical Ltd (ITMR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Itamar Medical Ltd (ITMR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-02$12.77 million-$0.21-$0.13-63.68%
2020-09-302020-11-17$11 million-$0.20-$0.16-29.03%
2020-06-302020-08-11$8.89 million-$0.23-$0.19-22.15%
2020-03-312020-05-27$8.38 million-$0.15-$0.14-5.63%
2019-12-312020-03-03$9.77 million-$0.09-$0.05-68.86%
2019-09-302019-11-26$8.08 million$-0.00-$0.1097%
2019-06-302019-08-14$7.35 million-$0.18-$0.13-38.46%
2019-03-312019-04-10$6.06 million-$0.12

Itamar Medical Ltd (ITMR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Itamar Medical Ltd (ITMR) Chart:

Itamar Medical Ltd (ITMR) News:

Below you will find a list of latest news for Itamar Medical Ltd (ITMR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Itamar Medical Ltd (ITMR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Itamar Medical Ltd (ITMR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920067933/0001104659-20-067933-index.htm
2020-01-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613170/000000000020000723/0000000000-20-000723-index.htm
2019-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919055713/0001104659-19-055713-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919058065/0001104659-19-058065-index.htm
2019-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919059228/0001104659-19-059228-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919063586/0001104659-19-063586-index.htm
2019-11-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919067193/0001104659-19-067193-index.htm
2019-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919069205/0001104659-19-069205-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919069762/0001104659-19-069762-index.htm
2019-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465919071593/0001104659-19-071593-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920003168/0001104659-20-003168-index.htm
2020-01-14DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1613170/000110465920003984/0001104659-20-003984-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920004120/0001104659-20-004120-index.htm
2020-01-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920004881/0001104659-20-004881-index.htm
2020-01-28F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1613170/000110465920007718/0001104659-20-007718-index.htm
2020-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1613170/000110465920007727/0001104659-20-007727-index.htm
2020-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1613170/000110465920007728/0001104659-20-007728-index.htm
2020-01-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920007734/0001104659-20-007734-index.htm
2020-01-29F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1613170/000110465920008115/0001104659-20-008115-index.htm
2020-01-30F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1613170/000110465920008884/0001104659-20-008884-index.htm
2020-01-31424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1613170/000110465920009321/0001104659-20-009321-index.htm
2020-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920009328/0001104659-20-009328-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000110465920016172/0001104659-20-016172-index.htm
2020-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920016302/0001104659-20-016302-index.htm
2020-03-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920028173/0001104659-20-028173-index.htm
2020-03-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613170/000110465920029134/0001104659-20-029134-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920032141/0001104659-20-032141-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920035665/0001104659-20-035665-index.htm
2020-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920036632/0001104659-20-036632-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613170/000110465920043200/0001104659-20-043200-index.htm
2020-04-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920045728/0001104659-20-045728-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920048478/0001104659-20-048478-index.htm
2020-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920055804/0001104659-20-055804-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920066026/0001104659-20-066026-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920067933/0001104659-20-067933-index.htm
2020-07-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920083768/0001104659-20-083768-index.htm
2020-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920086822/0001104659-20-086822-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920092941/0001104659-20-092941-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920094429/0001104659-20-094429-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920097019/0001104659-20-097019-index.htm
2020-08-206-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920097057/0001104659-20-097057-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920114049/0001104659-20-114049-index.htm
2020-10-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920115760/0001104659-20-115760-index.htm
2020-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000110465920120694/0001104659-20-120694-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000114420419039710/0001144204-19-039710-index.htm
2019-08-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613170/000114420419041020/0001144204-19-041020-index.htm
2019-09-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000117891319002335/0001178913-19-002335-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000117891320000286/0001178913-20-000286-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000117891320000391/0001178913-20-000391-index.htm
2020-02-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000117891320000554/0001178913-20-000554-index.htm
2019-08-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000119312519216958/0001193125-19-216958-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613170/000121390020003043/0001213900-20-003043-index.htm
2020-01-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1613170/999999999520000200/9999999995-20-000200-index.htm